Immunosuppressive Compounds Affect the Fungal Growth and Viability of Defined Aspergillus Species

Abstract

Immunosuppressive drugs are administered to a number of patients; e.g., to allogeneic hematopoietic stem cell transplant recipients. Immunosuppressive drugs impair the immune system and thus increase the risk of invasive fungal disease, but may exhibit antifungal activity at the same time. We investigated the impact of various concentrations of three commonly used immunosuppressive compounds—cyclosporin A (CsA), methylprednisolone (mPRED), and mycophenolic acid (MPA)—on the growth and viability of five clinically important Aspergillus species. Methods included disc diffusion, optical density of mycelium, and viability assays such as XTT. MPA and CsA had a species-specific and dose-dependent inhibitory effect on the growth of all Aspergillus spp. tested, although growth inhibition by MPA was highest in A. niger, A. flavus and A. brasiliensis. Both agents exhibited species-specific hyphal damage, which was higher when the immunosuppressants were added to growing conidia than to mycelium. In contrast, mPRED increased the growth of A. niger, but had no major impact on the growth and viability of any of the other Aspergillus species tested. Our findings may help to better understand the interaction of drugs with Aspergillus species and ultimately may have an impact on individualizing immunosuppressive therapy.

Global Transcriptomic Profiling of Innate and Adaptive Immunity During Aspergillus flavus Endophthalmitis in a Murine Model

“…Interestingly, it is also reported to have antifungal activity especially on Aspergillus spp rendering it as a favorable therapeutic option. 69 Whereas the involvement of adaptive immunity 72 hours post-infection is accredited, the involvement of innate immunity is not inconsequential. Pathways like NOD-like receptor signaling pathway 70 and PI3K-Akt signaling pathways are reported to play a major role in immune cell activation especially neutrophils and mast cells suggesting that the innate immunity is still a significant part in the host-immune response.…”

Diagnosis of invasive respiratory mycoses in the immunocompromised host

“…Glucocorticosteroids cause wide-ranging immune aberrations increasing risk of IFRI in a dose dependent manner [16]. They also have direct species-specific effects promoting fungal growth [17]. Dexamethasone used in the context of coronavirus disease 2019 (COVID-19)-induced immunopathology and epithelial injury contributes to devastating fungal co-infections [18 ▪▪ ].…”

Modulatory immune responses in fungal infection associated with organ transplant - advancements, management, and challenges

“…One of the most frequently used immunosuppressive mycophenolate mofetil, having established antifungal properties, can contribute to organ transplantation to eliminate commensal and unwanted fungal species or isolates. This immunosuppressive will consequently favor the invasive and mycophenolic acid-resistant species ( 379 ), hence could lead to invasive fungal infection burden, for example, in kidney recipients ( 380 ). After validation, this treatment direction can potentially lead to the development of molecular signatures of fungal resistance to immunosuppressants, which can be used as detecting tools to forecast clinical outcomes.…”